Mandate

Vinge advises FSN Capital in connection with the acquisition of Seriline

Vinge advises FSN Capital in connection with the acquisition of a majority stake in Seriline AB from its current shareholders, who will retain a sizable stake in the company.

Serline was founded in 1990 and is a provider of Identity and Access Management (IAM) solutions. Seriline offers proprietary software, online solutions, hardware and services that simplify the flow to creating user-friendly processes for confidentiality and integrity management of identities. Seriline has 29 FTEs and had SEK 84m in sales in 2021. The company is expected to be the initial platform in FSN’s buy-and-build strategy to create a Nordic cybersecurity leader within IAM.

Established in 1999, FSN Capital Partners is a leading Northern European private equity firm and investment advisor to the FSN Capital Funds, with €4 billion under management. FSN Capital Funds make control investments in growth-oriented Northern European companies, to support further growth and to transform companies into more sustainable, competitive, international, and profitable entities. 

Vinge’s team mainly consisted of Johan Winnerblad, Maria Dahlin Kolvik, Eléonore Friberg and Ebba Nyberg (M&A), Mathilda Persson and Karolina Fuhrman (IT/GDPR), Martin Boström (Commercial agreements), Felix Möller (Bank and Finance), Gustav Lindgren (Arbetsrätt), Sofia Bergenstråhle och Axel Lennartsson (IP), Tove Lövgren Frisk (Compliance), Ellinor Gyllenhammar and Elin Kollin (VDR).

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025